Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure

Journal of the American College of Cardiology

Volumn 35, Issue 1, 2000, Pages 56-59

  Gottlieb, Stephen S ^a   Skettino, Sandra L ^b   Wolff, Andrew ^c   Beckman, Evan ^d   Fisher, Michael L ^a   Freudenberger, Ronald ^c   Gladwell, Tim ^a   Marshall, Joanne ^c   Cines, Michelle ^b   Bennett, Donald ^d   Liittschwager, Elizabeth B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b DVA Medical Center   (United States)

^c CV THERAPEUTICS INC   (United States)

^d BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR; FUROSEMIDE; NAXIFYLLINE; PLACEBO; SODIUM; WATER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIURESIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; NATRIURESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING;

ADULT; AGED; DIURETICS; DOUBLE-BLIND METHOD; FEMALE; FUROSEMIDE; GLOMERULAR FILTRATION RATE; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NATRIURESIS; RECEPTORS, PURINERGIC P1; WATER-ELECTROLYTE BALANCE; XANTHINES;

EID: 0033955058     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00532-X     Document Type: Article

References (21)

1. Edlund A, Ohlsen H, Sollevi A. Renal effects of local infusion of adenosine in man. Clin Sci 1994;87:143-9.
2. Marraccini P, Fedele S, Marzilli, et al. Adenosine-induced renal vasoconstriction in man. Cardiovasc Res 1996;32:949-53.
3. Balakrishnan VS, Coles GA, Williams JD. Effects of intravenous adenosine on renal function in healthy human subjects. Am J Physiol 1996;40:F374-81.
4. Munger KA, Jackson EK. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renm-angiotensin system. Am J Physiol 1994;36:F783-90.
5. Tauxe WN, Dubovsky EV, Kidd T, Jr, Diaz F, Smith LR. New formulas for the calculation of effective renal plasma flow. Eur J Nucl Med 1982;7:51-4.
6. LaFrance ND, Drew HH, Walser M. Radioisotope measurement of glomerular filtration rate in severe chronic renal failure. J Nucl Med 1988;29:1927-30.
7. Beutler JJ, Boer WH, Koomans HA, Dorhout Mees EJ. Renal hemodynamic and tubular response to furosemide in man during normal and restricted sodium intake. Nephron 1990;54:208-13.
8. Scherzer P, Wald H, Popovtzer MM. Enhanced glomerular filtration rate and Na + -K+-ATPase with furosemide administration. Am J Physiol 1987;252:F910-5.
9. Tenstad O, Williamson HE. Effect of furosemide on local and zonal glomerular filtration rate in the rat kidney. Acta Physiol Scand 1995;155:99-107.
10. Lunau HE, Bak M, Peterson JS, Shalmi M, Marcussen N, Christensen S. Renal adaptations to continuous administration of furosemide and bendroflumethiazide in rats. Pharmacol Toxicol 1994;74: 216-22.
11. Smith FG, Abraham J. Renal and renin responses to furosemide in conscious lambs during postnatal maturation. Can J Physiol Pharmacol 1995;73:107-12.
12. Skott P, Hommel E, Bruun NE, Arnold-Larsen S, Parving H-H. The acute effect of acetazolamide on glomerular filtration rate and proximal tubular reabsorption of sodium and water in normal man. Scand J Clin Lab Invest 1989;49:583-7.
13. Bollerup AC, Hesse B, Sigurd B. Changes of glomerular filtration rate and renal plasma flow following intravenous bumetanide in organic heart disease. Acta Pharmacol Toxicol 1974;34:305-11.
14. Mackay IG, Muir AL, Watson ML. Contribution of prostaglandins to the systemic and renal vascular response to frusemide in normal man. Br J Clin Pharmacol 1984;17:513-9.
15. Okusa MD, Persson AE, Wright FS. Chlorothiazide effect on feedback-mediated control of glomerular filtration rate. Am J Physiol 1989;257:F137-44.
16. Elkayam U, Mehra A, Cohen G, et al. Renal circulatory effects of adenosine in patients with chronic heart failure. J Am Coll Cardiol 1998;32:211-5.
17. Balakrishnan VS, Coles GA, Williams JD. A potential role for endogenous adenosine in control of human glomerular and tubular function. Am J Physiol 1993;265:F504-10.
18. 1-receptor antagonist in anesthetized dogs. Biol Pharm Bull 1994;17:1599-603.
19. Arakawa K, Suzuki H, Naitoh M, et al. Role of adenosine in the renal responses to contrast medium. Kidney Int 1996;49:1199-1206.
20. Nagashima K, Kusaka H, Karasawa A. Protective effects of KW-3902, an adenosine A1-receptor antagonist, against cisplatin-induced acute renal failure in rats. Jpn J Pharmacol 1995;67:349-57.
21. Funaya H, Kitakaze M, Node K, Minammo T, Komamura K, Hori M. Plasma adenosine levels increase in patients with chronic heart failure. Circulation 1997;95:1363-5.